LifeStance Health Group (NASDAQ:LFST) Hits New 1-Year High – Should You Buy?

Posted by Geri Gentry on Aug 20th, 2026

LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) hit a new 52-week high during trading on Tuesday . The stock traded as high as $12.88 and last traded at $12.6580, with a volume of 9562 shares. The stock had previously closed at $12.55.

Analyst Ratings Changes

A number of equities research analysts recently commented on the stock. Barclays upped their price target on shares of LifeStance Health Group from $9.00 to $13.00 and gave the company an “overweight” rating in a report on Tuesday, July 14th. Wall Street Zen upgraded shares of LifeStance Health Group from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 15th. Weiss Ratings raised shares of LifeStance Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, August 11th. Zacks Research lowered shares of LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a report on Monday, July 13th. Finally, JPMorgan Chase & Co. raised their target price on LifeStance Health Group from $9.00 to $13.00 and gave the stock a “neutral” rating in a research note on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $12.38.

Read Our Latest Report on LifeStance Health Group

LifeStance Health Group Price Performance

The business has a 50 day moving average of $10.68 and a 200 day moving average of $8.34. The company has a market cap of $4.98 billion, a PE ratio of 98.70 and a beta of 1.14. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.38 and a quick ratio of 1.38.

LifeStance Health Group (NASDAQ:LFST – Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.03 by $0.03. LifeStance Health Group had a net margin of 3.19% and a return on equity of 3.39%. The business had revenue of $435.35 million for the quarter, compared to the consensus estimate of $414.58 million. During the same period in the previous year, the firm earned ($0.01) EPS. The company’s quarterly revenue was up 26.1% compared to the same quarter last year. As a group, research analysts predict that LifeStance Health Group, Inc. will post 0.16 EPS for the current year.

Insider Activity at LifeStance Health Group

In other LifeStance Health Group news, Director Robert Bessler sold 894,337 shares of the firm’s stock in a transaction dated Friday, June 26th. The shares were sold at an average price of $10.13, for a total value of $9,059,633.81. Following the completion of the sale, the director directly owned 539,763 shares in the company, valued at $5,467,799.19. This trade represents a 62.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, major shareholder Tpg Gp A, Llc sold 13,643,207 shares of LifeStance Health Group stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $10.62, for a total value of $144,890,858.34. Following the sale, the insider directly owned 98,101,407 shares in the company, valued at approximately $1,041,836,942.34. The trade was a 12.21% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 14,629,850 shares of company stock worth $154,952,012 over the last ninety days. Corporate insiders own 3.50% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Larson Financial Group LLC grew its stake in LifeStance Health Group by 19,952.6% in the fourth quarter. Larson Financial Group LLC now owns 3,810 shares of the company’s stock worth $27,000 after purchasing an additional 3,791 shares during the period. KBC Group NV purchased a new position in LifeStance Health Group during the first quarter valued at $29,000. EverSource Wealth Advisors LLC lifted its position in LifeStance Health Group by 359.1% during the first quarter. EverSource Wealth Advisors LLC now owns 6,909 shares of the company’s stock valued at $44,000 after buying an additional 5,404 shares during the period. PNC Financial Services Group Inc. boosted its holdings in shares of LifeStance Health Group by 615.3% during the 1st quarter. PNC Financial Services Group Inc. now owns 9,285 shares of the company’s stock valued at $59,000 after buying an additional 7,987 shares in the last quarter. Finally, Assetmark Inc. boosted its holdings in shares of LifeStance Health Group by 17.0% during the 1st quarter. Assetmark Inc. now owns 9,419 shares of the company’s stock valued at $60,000 after buying an additional 1,367 shares in the last quarter. Hedge funds and other institutional investors own 85.50% of the company’s stock.

LifeStance Health Group Company Profile

(Get Free Report)

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.